Table 2.
Relationship between IL-1β content and clinical and pathological features in tumor tissues
| Clinical and pathological features | Sample size | IL-1β
|
||
|---|---|---|---|---|
| IL-1β level | Test statistics | P-value | ||
| Age, years | ||||
| 60 | 37 | 3.81 | −0.09 | 0.92 |
| ≤60 | 33 | 3.50 | ||
| Sex | ||||
| Male | 52 | 3.59 | −0.69 | 0.48 |
| Female | 18 | 4.04 | ||
| Blood type | ||||
| A | 25 | 3.59 | 1.56 | 0.66 |
| B | 13 | 3.06 | ||
| O | 22 | 4.91 | ||
| AB | 10 | 2.79 | ||
| Differentiated degree | ||||
| Stage I–II | 24 | 4.15 | −0.87 | 0.38 |
| Stage III | 46 | 3.21 | ||
| Invasion depth | ||||
| T1–T2 | 12 | 3.45 | −1.15 | 0.24 |
| T3–T4 | 58 | 3.06 | ||
| Number of lymph-node metastases | ||||
| N0 (0) | 15 | 3.31 | 0.80 | 0.84 |
| N1 (1–2) | 9 | 3.13 | ||
| N2 (3–6) | 28 | 3.59 | ||
| N3 (≥7) | 18 | 5.30 | ||
| Diameter of tumor | ||||
| ≥5 cm | 45 | 3.21 | −2.16 | 0.03 |
| <5 cm | 25 | 3.80 | ||
| Tumor site | ||||
| Antrum of stomach | 50 | 3.45 | 0.64 | 0.72 |
| Gastric body | 10 | 6.00 | ||
| Cardia of stomach | 10 | 3.16 | ||
| TNM staging | ||||
| I–II | 25 | 3.15 | −0.30 | 0.76 |